Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events

Area of Science:

• Cardiology
• Pharmacology
• Preventive Medicine

Background:

• Aspirin has been a standard for cardiovascular disease prevention since the 1980s.
• Current aspirin use lacks determined optimal dosing and frequency.
• Previous trials with broad populations showed increased complications without magnified benefits.

Purpose of the Study:

• To review current evidence on aspirin responsiveness in distinct patient populations.
• To analyze the rationale behind varied aspirin dosing and frequency strategies.
• To highlight the need for personalized aspirin therapy.

Main Methods:

• Comprehensive literature review of existing studies on aspirin therapy.
• Analysis of laboratory and clinical data on aspirin response diversity.
• Evaluation of different dosing and frequency strategies across patient groups.

Main Results:

• Patient response to aspirin therapy is highly variable.
• Broad population trials did not optimize aspirin's benefit-risk ratio.
• Individualized aspirin strategies are suggested by current evidence.

Conclusions:

• Tailored aspirin therapy is essential for optimizing cardiovascular prevention.
• Future research should focus on determining individualized aspirin strategies.
• Personalized approaches aim to maximize therapeutic benefits while minimizing adverse events.